Literature DB >> 26791119

Autoimmune hepatitis unmasked by nimesulide.

Rita Magalhães1, Margarida Fonseca1, Ilídio Brandão1, Sofia Caridade1.   

Abstract

A 49-year-old woman presented at the emergency department, with acute hepatic failure, 2 weeks after taking nimesulide. Presenting with a MELD score of 25.0, the patient was transferred to a specialised liver transplant unit, with the probable diagnosis of toxic hepatitis. After a clinical improvement with supportive care and acetylcysteine, a liver biopsy was executed. The histology revealed micronodular cirrhosis associated with acute hepatitis, with features suggestive of autoimmune hepatitis. The patient was then started on azathioprine 50 mg/day and prednisolone 30 mg/day, and tapering of prednisolone was carried out in the following months. Twenty eight months after treatment, another liver biopsy was performed, showing almost full remission of the disease, with only mild fibrosis and no significant inflammatory infiltrate. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26791119      PMCID: PMC4735412          DOI: 10.1136/bcr-2015-212884

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  40 in total

Review 1.  Autoimmune hepatitis.

Authors:  Edward L Krawitt
Journal:  N Engl J Med       Date:  2006-01-05       Impact factor: 91.245

2.  Liver failure as initial presentation of autoimmune hepatitis: clinical characteristics, predictors of response to steroid therapy, and outcomes.

Authors:  Sumita Verma; Anurag Maheshwari; Paul Thuluvath
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

Review 3.  Fibrosis--a common pathway to organ injury and failure.

Authors:  Don C Rockey; P Darwin Bell; Joseph A Hill
Journal:  N Engl J Med       Date:  2015-03-19       Impact factor: 91.245

4.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

5.  Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease.

Authors:  Agustin Castiella; Eva Zapata; M Isabel Lucena; Raúl J Andrade
Journal:  World J Hepatol       Date:  2014-04-27

Review 6.  Acute-on chronic liver failure.

Authors:  Rajiv Jalan; Pere Gines; Jody C Olson; Rajeshwar P Mookerjee; Richard Moreau; Guadalupe Garcia-Tsao; Vicente Arroyo; Patrick S Kamath
Journal:  J Hepatol       Date:  2012-06-28       Impact factor: 25.083

Review 7.  Autoimmune hepatitis: a comprehensive review.

Authors:  Rodrigo Liberal; Charlotte R Grant; Giorgina Mieli-Vergani; Diego Vergani
Journal:  J Autoimmun       Date:  2012-12-04       Impact factor: 7.094

8.  Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis.

Authors:  William R Kessler; Oscar W Cummings; George Eckert; Naga Chalasani; Lawrence Lumeng; Paul Y Kwo
Journal:  Clin Gastroenterol Hepatol       Date:  2004-07       Impact factor: 11.382

9.  Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs.

Authors:  Luisa Ibáñez; Eulàlia Pérez; Xavier Vidal; Joan Ramon Laporte
Journal:  J Hepatol       Date:  2002-11       Impact factor: 25.083

10.  Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis.

Authors:  Albert J Czaja; Herschel A Carpenter
Journal:  J Hepatol       Date:  2004-04       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.